Pfizer vaccine recipients have lower antibodies targeting Indian variant – study

Researchers say this provides additional evidence in support of plans to deliver a vaccination boost to vulnerable people in the autumn.

Pfizer vaccine recipients have lower antibodies targeting Indian variant. Picture: Nick Potts/PA

People who have had the Pfizer/BioNTech vaccine have lower antibody levels targeting the coronavirus variant first discovered in India than those against previously circulating variants in the UK, new data suggests.

The research also suggests the levels of these antibodies are lower with increasing age and that levels decline over time.